Mesenchymal stem cells (MSCs) are known to facilitate angiogenesis and promote neo-vascularization via secretion of trophic factors. Here, we explored the molecular mechanism adopted by ADAMTS13 in modulating the expression of some key angiogenic markers
Srishti Dutta Gupta, Malancha Ta
doaj +1 more source
ADAMTS13 bei herzchirurgischen Patienten
Im Rahmen dieser Masterarbeit wurde die ADAMTS13 Aktivität über vorab definierte Messzeitpunkte beschrieben und zwischen relevanten Eingriffscharakteristika und laborchemischen Parametern mittels Korrelationsanalysen verglichen.
Humer, Julia Katharina
core
Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening disease, which is caused by a deficiency of the blood protease ADAMTS13.
Roose, E.
core
The Highs and Lows of ADAMTS13 Activity
Severe deficiency of ADAMTS13 (
Cheng-Hock Toh +9 more
core +1 more source
Current standards and novel concepts in thrombotic thrombocytopenic purpura. [PDF]
Bloehdorn J, Cragg MS, Bommer M.
europepmc +1 more source
Sepsis-associated thrombotic microangiopathy-like syndrome following cardiac surgery: a case report. [PDF]
Yang C +6 more
europepmc +1 more source
The absence of ADAMTS13 improves early outcomes in an experimental model of trauma with uncontrolled hemorrhage. [PDF]
Sloos PH +10 more
europepmc +1 more source
Diagnosis and monitoring of thrombotic thrombocytopenic purpura: Guidance for laboratories from the British Society for Haematology. [PDF]
MacDonald S +8 more
europepmc +1 more source
Unintended Interruption of Caplacizumab Therapy Can Compromise Outcomes in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Lessons from Two Clinical Cases. [PDF]
Özcan F +5 more
europepmc +1 more source
Therapeutic Plasma Exchange in Immune-Mediated Thrombotic Thrombocytopenic Purpura: From Cornerstone to Contextualized Therapy. [PDF]
Özcan F, Brinkhoff A, Wendt R.
europepmc +1 more source

